23 Sep 2009
A finance director is facing insider dealing charges at the Crown Court after allegedly passing on information about the proposed takeover of Neutec Pharma, a company which develops treatments for life-threatening infections.
The FSA said Peter Andrew King is charged with disclosing inside information relating to the proposed takeover of Neutec Pharma to a lawyer Michael McFall, "having had that inside information by virtue of being Neutec Pharma plc’s finance director, and disclosing it to Michael McFall other than in the proper performance of his job."
McFall allegedly passed the information on to another lawyer Andrew Rimmington before they both bought shares in Neutec Pharma, which was founded by two university professors in 1997.
Following a contested hearing which took place at Westminster Magistrates Court, District Judge Miss Tubbs remanded King, McFall and Rimmington on unconditional bail to appear at Southwark Crown Court for a plea and case management hearing on 28 October 2009.
Related links:
You may also like
Careers
Search for jobs
Click to search our database of all the latest accountancy roles
Create a profile
Click to set up your profile and let the best recruiters find you
Jobs by email
Sign up to receive regular updates with the latest roles suitable for you
Briefings
By looking at the reasons supplier statements became unfashionable, and the reasons why it is different today, this paper delves into the many benefits that can be obtained by automating the process.
Having a real and true view of your organisation’s current financial position, and having the right systems and processes in place, will ensure that you can make strong choices and are ready to capitalise on opportunities
Visitor comments Add your comment